Patents by Inventor Saori Furuta

Saori Furuta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detecting and treating breast cancer resistance to EGFR inhibitors
    Patent number: 9303088
    Abstract: The application describes therapeutic compositions and methods for treating cancer. For example, therapeutic compositions and methods related to inhibition of FAM83A (family with sequence similarity 83) are provided. The application also describes methods for diagnosing cancer resistance to EGFR inhibitors. For example, a method of diagnosing cancer resistance to EGFR inhibitors by detecting increased FAM83A levels is described.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: April 5, 2016
    Assignee: The Regents of the University of California
    Inventors: Sun-Young Moonlee, Mina J. Bissell, Saori Furuta, Roland Meier, Paraic A. Kenny
  • USE OF IL-17E FOR CANCER TREATMENT
    Publication number: 20130052157
    Abstract: The present invention provides methods, kits, and compositions for treating cancer with cytotoxic agents. Preferably, the cytotoxic agents are selected from: IL-25, BMP1O, FGF1 1, VDBP, ATIII and IL1-F7, and any combination thereof. In other preferred embodiments, the cancer is breast cancer. These agents can be supplied, for example, as proteins or as part of nucleic acid expression vector.
    Type: Application
    Filed: April 13, 2009
    Publication date: February 28, 2013
    Applicant: The Regents of the University of California
    Inventors: Saori Furuta, Mina J. Bissell, Wen-Hwa Lee, Eva Yhp Lee
  • DETECTING AND TREATING BREAST CANCER RESISTANCE TO EGFR INHIBITORS
    Publication number: 20120094843
    Abstract: The application describes therapeutic compositions and methods for treating cancer. For example, therapeutic compositions and methods related to inhibition of FAM83A (family with sequence similarity 83) are provided. The application also describes methods for diagnosing cancer resistance to EGFR inhibitors. For example, a method of diagnosing cancer resistance to EGFR inhibitors by detecting increased FAM83A levels is described.
    Type: Application
    Filed: September 29, 2011
    Publication date: April 19, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Roland Meier, Sun-Young Moonlee, Paraic A. Kenny, Mina J. Bissell, Saori Furuta